Fagan Associates’s Edwards Lifesciences EW Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$242K	Hold	3,092	–	–	0.04%	117
2025 Q1	$224K	Sell	3,092 -800	-21%	-$58K	0.04%	119
2024 Q4	$288K	Sell	3,892 -580	-13%	-$42.9K	0.05%	120
2024 Q3	$295K	Hold	4,472	–	–	0.05%	115
2024 Q2	$413K	Sell	4,472 -205	-4%	-$18.9K	0.07%	97
2024 Q1	$447K	Hold	4,677	–	–	0.08%	98
2023 Q4	$357K	Hold	4,677	–	–	0.08%	92
2023 Q3	$324K	Sell	4,677 -48	-1%	-$3.33K	0.08%	93
2023 Q2	$446K	Hold	4,725	–	–	0.11%	84
2023 Q1	$391K	Buy	4,725 +48	+1%	+$3.97K	0.1%	93
2022 Q4	$349K	Hold	4,677	–	–	0.09%	99
2022 Q3	$386K	Hold	4,677	–	–	0.11%	92
2022 Q2	$445K	Hold	4,677	–	–	0.12%	89
2022 Q1	$551K	Hold	4,677	–	–	0.11%	96
2021 Q4	$606K	Hold	4,677	–	–	0.12%	93
2021 Q3	$529K	Sell	4,677 -80	-2%	-$9.05K	0.12%	94
2021 Q2	$493K	Buy	4,757 +1,256	+36%	+$130K	0.11%	100
2021 Q1	$293K	Sell	3,501 -34	-1%	-$2.85K	0.07%	110
2020 Q4	$322K	Sell	3,535 -100	-3%	-$9.11K	0.08%	101
2020 Q3	$290K	Sell	3,635 -100	-3%	-$7.98K	0.08%	96
2020 Q2	$258K	Buy	3,735 +2,490	+200%	+$172K	0.08%	96
2020 Q1	$235K	Sell	1,245 -70	-5%	-$13.2K	0.09%	94
2019 Q4	$307K	Hold	1,315	–	–	0.1%	103
2019 Q3	$289K	Hold	1,315	–	–	0.11%	101
2019 Q2	$243K	Hold	1,315	–	–	0.1%	106
2019 Q1	$252K	Hold	1,315	–	–	0.11%	103
2018 Q4	$201K	Hold	1,315	–	–	0.1%	105
2018 Q3	$229K	Sell	1,315 -64	-5%	-$11.1K	0.09%	110
2018 Q2	$201K	Buy	+1,379	New	+$201K	0.09%	111